Experiences with recombinant factor VIIa for the prevention of bleeding in patients with chronic liver disease undergoing percutaneous liver biopsies and endoscopic retrograde cholangiopancreatography (ERCP).

Authors :: Kositchaiwat C
Chuansumrit A
Source :: Thrombosis and haemostasis [Thromb Haemost] 2001 Oct; Vol. 86 (4), pp. 1125-6.
Publication Year :: 2001

Subjects :: Adult
Aged
Factor VIIa genetics
Female
Fibrin Fibrinogen Degradation Products analysis
Hemorrhage etiology
Humans
Liver pathology
Male
Middle Aged
Partial Thromboplastin Time
Prothrombin Time
Recombinant Proteins therapeutic use
Treatment Outcome
Biopsy, Needle adverse effects
Cholangiopancreatography, Endoscopic Retrograde adverse effects
Factor VIIa therapeutic use
Hemorrhage prevention & control
Liver Diseases complications

Tools